Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Hits & Misses
    • Artificial Intelligence and Healthcare
    • Doctors & Hospitals
      • COVID-19 and Public Health
    • Policy & Legislation
      • Affordable Care Act
    • Health Economics & Costs
      • Cost of Healthcare
      • Drug Prices & Regulations
      • Health Reform
    • Health Insurance
      • Public Insurance
      • Medicare
    • Telemedicine
      • Medical Tourism
  • Goodman Institute
  • Contact
  • Search
The Goodman Institute Health Blog

Category: Drug Prices & Regulations

Consumer Reports: Mail order may be cheaper when shopping for drugs

Posted on April 18, 2022 by Devon Herrick

Nearly two-thirds of adults (62%) take at least one prescription drug. Of Americans on a drug, nearly one-third (30%) report either not filling a prescription or not taking it as directed due to the cost. Even people with prescription drug coverage often find drug copays are costly. According to Kaiser Family Foundation, the average copay for a generic drug is only $12 but many copays are much higher.

+

Friday Links

Posted on April 15, 2022April 15, 2022 by John C. Goodman

Telemedicine is being used for assisted dying.

Why was a Texas woman charged with murder over a self-induced abortion?

Will 10,000 steps a day make you healthier? No. 7,000 steps seems to get the job done.

Why do companies invest in finding drugs to treat rare diseases?

How did the Middle Ages respond to the Back Death? With price controls and more. (recommended)

+

Why am I not surprised? Teens who abuse drugs don’t stop as adults

Posted on April 5, 2022 by Devon Herrick

Once teenage drug users reach adulthood are they safely past the likelihood of future drug abuse? No, not according to research. A study followed 5,300 teens all the way to age 50.

+

Should the FDA Require Proof that High-Priced Drugs Actually Work?

Posted on April 4, 2022April 4, 2022 by Devon Herrick

An advisory committee at the U.S. Food and Drug Administration (FDA) recently voted against fast-track approval for an experimental drug to treat amyotrophic lateral sclerosis (ALS). ALS is also known as Lou Gehrig’s disease. You can watch the committee meeting, and learn more, in this post.

+
  • Previous
  • 1
  • …
  • 254
  • 255
  • 256
  • 257
  • 258
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 45 other subscribers

Popular Topics

©2026 The Goodman Institute Health Blog | Website by Lexicom